Seattle Genetics

Padcev

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / Padcev – J9177

Manufacturer:

Seattle Genetics

Name:

Padcev

HCPCS Code Descriptor:

Injection, enfortumab vedotin-ejfv, 0.25 mg

Category:

J Code

HCPCS:

J9177

NDC(s):

51144-0030-01, 51144-0020-01

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

Padcev is an Oncology drug manufactured by Seattle Genetics and administered via the Intravenous route of administration. The J Code: J9177 is aligned to the drug Padcev.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

7/1/20

HCPCS Effective Date:

7/1/20

HCPCS Short Description:

Inj enfort vedo-ejfv 0.25mg

Billing and Coding Guide:

https://astellaspharmasupportsolutions.com/docs/padcev/PADCEV_Coding_Billing_Guide.pdf

Patient Assistance:

https://astellaspharmasupportsolutions.com/patient/padcev/index.aspx